$XXII descending wedge along with bollies pinching NASDAQ:XXII descending wedge along with bollies pinching. Recipe is there for a big reversal from this bottom support. Key level to hold is .25.
XXII trade ideas
XXII Watch news POP to $6Timing markets is almost impossible, but I'm saying I have timing (from dowsing & intuition) for news in this on Monday... Could also be Tuesday, but it's coming. I was getting September 11th in meditations through the year starting on 3/12 with the message of "good news" for XXII.
I have tons of timing around now into Monday for it. Meaning when I've asked advice my dowsing suggests getting a date and this date zone comes repeatedly. When I ask what's important about this time I get that there's news that sends prices up, there's multi-days of buying and it's an "extreme value buy".
I would not hold much of it past 9/18, however, as I literally received instructions to do a partial sell on that date.
The price target is almost $6. I also got $7... Actually, I think this is just the universe playing with me cuz I ask for the "cents" after $7 target & get .77. Like, maybe it's suggesting the lucky 777 from a slot machine. That actually could be a good thing. This stock owes me LOL. And a lot of other people. I'm ready!
XXII longer term investment This one has been MANY YEARS in the making and at long last is about to have it's moment in the sun. You can read about the company, but it's a solid idea fundamentally and there is an FDA decision for a mandate coming down the pike in August or September.
I had dowsed this thing for a long time and had the low coming in June. Then, they had a reverse stock split 1:15, so this thing was like, in the dirt manipulated by shorts every day.
Volume is coming in and shorts are done imo. Let's goooo!
Ultimate target next March (should be trending up well) and I'm looking for $60-65.
I also have dates for July 25th (could be a dip if it goes up into that, or nothing at all).
Date of Aug. 17th. Sept. 11 came in meditation back in March for a "life saver" & date 9/18.
Date 10/23 and I think that's all
$XXII NASDAQ:XXII
On Thursday, July 20, 2023, the stock price of 22nd Century Group experienced high volatility and ended the trading session at $3.70. During the day, the stock price surged by 35.04%, rising from $2.74 to $3.70. This marked the fourth consecutive day of gains for the stock. Investors are now eager to see whether the stock will continue its upward trend or take a minor pause in the coming days.
Throughout the trading day, the stock's price fluctuated significantly, ranging from a low of $2.68 to a high of $4.00, indicating considerable market activity. Over the past 10 days, the stock has risen in 6 of them, accumulating an impressive 37.04% gain over the past 2 weeks. The increase in trading volume on the last day, coupled with the rising price, is considered a positive technical signal. In total, 6 million more shares were traded compared to the previous day, with a total of 7 million shares exchanged for approximately $25.79 million.
Currently, the stock is in the upper part of a very wide and strong rising trend in the short term, presenting an opportunity for short-term traders to consider selling, as a reaction back towards the lower part of the trend might be anticipated. A break above the top trend line at $4.07 would suggest an even stronger rate of ascent.
Based on the current short-term trend, the stock is projected to rise by 71.47% over the next 3 months, with a 90% probability of holding a price between $1.08 and $6.97 at the end of this 3-month period.
As with any investment decision, it is essential to conduct thorough research and analysis before making any financial moves. While the recent performance of the stock appears positive, investing in the stock market carries inherent risks, and it's crucial to assess the company's fundamentals and market conditions before making any investment choices.
XXII - Falling WedgeOn the chart we see a falling wedge occurring. We are expecting a breakout in the near future.
There are regular bullish divergence that will play out at some point.
The stock is down 87% from its ATH. The trend reversal may be around the corner.
Target is shown on the chart - good luck!
$XXII 10~yr pennantThere's plenty of research that can be done on why I am fundamentally holding this long term. It's getting into zones I am comfortable adding to the position. There are outside forces that have kept this stock beaten down for many years as they are the major big tobacco killer, as a micro-cap. My outlook is that when the switch flips and tides turn, this stock can be explosive, and the 10 year pennant has big upside.
Recent direct offering done at 2.05, currently 1.60. The long term equilibrium zone is roughly 1.40-1.70, I am a buyer, adding slowly here, and will continue to add sub 1.30.
The last year and a half the stock has been trading in a downward channel. Looking at previous 1-2 year periods, there are larger scale macro patterns that tend to form and play out.
Recent progress and development of their company key driving force in VLN, has become more and more a reality. Despite the company being in a great position after years of the rigorous FDA process, it's the final stretch for them as their product is now on shelves.
Pair that with being on the lower end of the range here, with earnings coming up and an update on their pilot program, I am adding to the long holds.
Roughly 7 years I've been following this company closely, swing trading it up and down. The recent direct offering with warrants gave investors the opportunity to short, but I believe it will be a short-lived downturn. The time horizon is 12 months for a macro reversal here to break the channel.
XXII Daily chart. Big news today (6-21)Today XXII was featured in breaking news stories in the WSJ and the NYTIMES. Should be a major catalyst... but who knows!
Biden Administration Targets Removal of Most Nicotine From Cigarettes -- WSJ
"...22nd Century Group Inc., a Buffalo-based biotechnology company, uses genetic engineering to grow tobacco with about 95% less nicotine than a typical tobacco plant for a cigarette brand called VLN. The product is currently available for sale in Chicago. 22nd Century has also supplied more than 30 million cigarettes at varying nicotine levels for scientific research.
22nd Century is willing to partner with other cigarette companies to provide tobacco seeds, Chief Executive James Mish said. "It's immediately scalable," he said."
-----------------------
www.nytimes.com
F.D.A. Aims to Cut Down on Smoking by Slashing Nicotine Levels in Cigarettes
"Low-nicotine cigarettes are already available to consumers, albeit in a limited fashion. This spring, a New York plant biotech company, 22nd Century Group, began selling a reduced-nicotine cigarette that took 15 years and tens of millions of dollars to develop through the genetic manipulation of the tobacco plant. The company’s brand, VLN, contains 5 percent of the nicotine level of conventional cigarettes, according to James Mish, the company’s chief executive.
“This is not some far-off technology,” he said.
To earn its F.D.A. designation as a “reduced-risk” tobacco product, VLN was subjected to a raft of testing and clinical trials by regulators.
For now, the company is selling VLN at Circle K convenience stores in Chicago as part of a pilot program. Mr. Mish described sales as “modest” — retail prices are similar to premium brands like Marlboro Gold — but he said the F.D.A. proposal would most likely accelerate plans for a national rollout in the coming months."
